School of Medicine
Showing 9,441-9,460 of 13,055 Results
-
Samantha Reyes
Postdoctoral Scholar, Molecular Imaging Program at Stanford
BioResearch Interests: Preclinical and clinical PET imaging, novel tracer validation in vivo, B cell role in multiple sclerosis and pharmacokinetic modelling
Samantha is a Biomedical Physics PhD student with extensive experience in multi-modal molecular imaging of neurological diseases and a strong background in synthetic chemistry. She helped validate both a novel sigma-1 radiotracer, [18F]FTC-146, for its ability to detect molecular markers of neuropathic pain non-invasively and a [64Cu]hCD19-mAb radiotracer for imaging therapy-induced B cell depletion. She is well-versed in pharmacokinetic modeling, receptor occupancy studies, autoradiography, and cell-based assays. Moreover, is an expert in PET/MR imaging of neonatal mice. -
Eman Rezk
Affiliate, Rad/Integrative Biomedical Imaging Informatics at Stanford
Visiting Postdoctoral Scholar, Rad/Integrative Biomedical Imaging Informatics at StanfordBioPostdoctoral researcher, Royal Society of Canada award recipient, and NSERC scholar, specializing in AI-driven healthcare solutions with a focus on equitable diagnostics.
-
Andrew Rezvani, M.D.
Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Current Research and Scholarly InterestsClinical research in allogeneic hematopoietic cell transplantation
-
James H Rhee
Clinical Assistant Professor, Orthopaedic Surgery
BioDr. Rhee is a physiatrist and a clinical assistant professor of physical medicine and rehabilitation. For patients with spine and musculoskeletal conditions, he focuses on providing exceptional care emphasizing minimally invasive solutions designed to optimize symptom managementand patient function.
Building on his background in engineering and on his specialized medical training and experience, Dr. Rhee welcomes opportunities to combine medical, mechanical, and interpersonal approaches to the diagnosis and treatment of each patient. He offers a full range of treatment modalities, including epidural steroid injection procedures, sacroiliac and facet joint injections, trigger point and soft tissue injections, orthopedic joint injections, and more. He also provides medial branch blocks and radiofrequency ablations, and performs electrodiagnostic studies.
Among the wide range of conditions that Dr. Rhee treats are bursitis, herniated discs, radiculopathy, sciatica, spinal stenosis, spondylolisthesis, and spondylosis. He also has treated many forms of joint and muscle pain: facet joint, back, neck, hip, and sacroiliac joint pain.
Dr. Rhee’s experience encompasses short-term and long-term care for both acute and chronic conditions, including musculoskeletal injuries, spinal problems, mixed spine-neck and spine-shoulder disorders, and peripheral damage. Many of the cases he treats are injury-related, while a significant number of others are associated with aging. Another portion of his patient population presents with conditions stemming from developmental anomalies.
Prior to joining Stanford Health Care, Dr. Rhee was in private practice in the Bay Area. Previously, he also served in the US Army as a troop medical clinic officer-in-charge and as a brigade surgeon.
Dr. Rhee is board certified by the American Board of Physical Medicine and Rehabilitation. He is a fellow of the American Academy of Physical Medicine and Rehabilitation and a member of the American Society of Interventional Pain Physicians, North American Spine Society, and Spine Intervention Society. -
William Rhine
Professor of Pediatrics (Neonatology), Emeritus
Current Research and Scholarly InterestsNeonatology, extracorporeal membrane oxygenation, nitric oxide therapy, mechanisms of bilirubin toxicity and brain injury, non-invasive biotechnologies to study cellular and organ metabolism.
-
Fauzia Riaz, MD, MHS
Assistant Professor of Medicine (Oncology)
BioDr. Riaz is advancing biomarker-driven precision medicine in breast cancer through innovative clinical trials that integrate cutting-edge therapeutics and molecular insights.
Her research focuses on circulating tumor DNA (ctDNA) to detect minimal residual disease (MRD) in early-stage breast cancer, aiming to guide personalized treatment strategies. She is also developing novel approaches to enhance immunotherapy efficacy by modulating the tumor microenvironment, including early-phase trials that combine immunotherapy with radiotherapy. As an Assistant Professor at Stanford University School of Medicine, Dr. Riaz is committed to ensuring that these next-generation therapies are accessible to all patients..
